Pliant Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
PLRX on Nasdaq
Location
331 Oyster Point Boulevard, South San Francisco, CA

Insiders trading volume in the past year

Pliant Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Third Rock Ventures III, L.P. 10%+ Owner $68.4M Nov 29, 2022
Bernard Coulie President and CEO, Director $11M -$587K -5.06% Jan 23, 2025
Keith Lamont Cummings Chief Financial Officer $3.51M -$226K -6.04% Jan 23, 2025
Hans Hull Chief Business Officer $2.92M -$179K -5.76% Jan 23, 2025
Eric Lefebvre Chief Medical Officer $2.64M -$207K -7.27% Jan 23, 2025
Mike Ouimette General Counsel & Corp. Sec'y $1.16M -$261K -18.4% Jan 23, 2025
Lily Cheung Chief Human Resource Officer $554K -$41.9K -7.03% Jan 23, 2025
E. Krognes Director $111K Jun 5, 2025
Suzanne Louise Bruhn Director $55.7K Jun 5, 2025
Smital Shah Director $55.7K Jun 13, 2024
E. Pyott David Director $55.7K Jun 5, 2025
Hoyoung Huh Director $55.7K Jun 5, 2025
John T. Curnutte Director $55.7K Jun 5, 2025
Gayle Crowell Director $55.7K Jun 5, 2025
Katharine Knobil Director $55.7K Jun 5, 2025
Darren S. Cline Director $55.7K Jun 5, 2025
Thomas A. MCCOURT Director $55.7K Jun 5, 2025
Neil Exter Director Jun 16, 2022
Charles J. Homcy Director Jun 29, 2021

Recent Insider Transactions by Companies or Individuals for Pliant Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.